Moloney Securities Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Moloney Securities Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,278	Closed	-$205K	–	520
2024 Q4	$205K	Sell	2,278 -55	-2%	-$5.33K	0.03%	413
2024 Q3	$230K	Sell	2,333 -274	-11%	-$26.9K	0.03%	413
2024 Q2	$242K	Buy	+2,607	New	+$234K	0.03%	390
2022 Q1	–	Sell	-2,146	Closed	-$240K	–	464
2021 Q4	$240K	Sell	2,146 -27	-1%	-$3.26K	0.04%	371
2021 Q3	$273K	Hold	2,173	–	–	0.05%	340
2021 Q2	$294K	Sell	2,173 -9	-0.4%	-$1.18K	0.05%	327
2021 Q1	$296K	Sell	2,182 -360	-14%	-$53.9K	0.06%	309
2020 Q4	$358K	Sell	2,542 -2,173	-46%	-$278K	0.08%	252
2020 Q3	$525K	Sell	4,715 -3,569	-43%	-$400K	0.14%	162
2020 Q2	$927K	Buy	+8,284	New	+$816K	0.27%	103
2020 Q1	–	Sell	-2,164	Closed	-$206K	–	360
2019 Q4	$206K	Buy	+2,164	New	+$187K	0.06%	321
2019 Q3	–	Sell	-2,368	Closed	-$208K	–	357
2019 Q2	$208K	Sell	2,368 -90	-4%	-$7.68K	0.07%	283
2019 Q1	$223K	Buy	+2,458	New	+$209K	0.08%	259
2018 Q4	–	Sell	-2,358	Closed	-$226K	–	314
2018 Q3	$226K	Hold	2,358	–	–	0.08%	254
2018 Q2	$224K	Hold	2,358	–	–	0.09%	253
2018 Q1	$207K	Sell	2,358 -42	-2%	-$3.83K	0.08%	263
2017 Q4	$204K	Sell	2,400 -840	-26%	-$70.4K	0.09%	240
2017 Q3	$280K	Buy	+3,240	New	+$260K	0.12%	194
2017 Q2	–	Sell	-3,517	Closed	-$244K	–	261
2017 Q1	$244K	Buy	3,517 +101	+3%	+$6.78K	0.13%	200
2016 Q4	$202K	Buy	+3,416	New	+$211K	0.12%	194

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Moloney Securities Asset Management's XBI Position: Q1 2025 in Review

Moloney Securities Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 2,278 shares — an estimated $205K sold.

Moloney Securities Asset Management first reported a position in XBI in Q4 2016 and held it in 20 quarters. The position peaked at $927K in Q2 2020. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Moloney Securities Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
Moloney Securities Asset Management sold 2,278 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $205K.
Moloney Securities Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 20 quarters.
Moloney Securities Asset Management's State Street SPDR S&P Biotech ETF position peaked at $927K in Q2 2020.
685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Moloney Securities Asset Management's 13F filing for Q1 2025, filed 30 Apr 2025.